An improved carbapenem inactivation method, CIMTrisII, for carbapenemase production by Gram-negative pathogens

J Med Microbiol. 2019 Feb;68(2):124-131. doi: 10.1099/jmm.0.000888. Epub 2018 Dec 10.

Abstract

The modified carbapenem inactivation method (mCIM) is a simple phenotypic screening method for detecting carbapenemase production by Enterobacteriaceae and Pseudomonas aeruginosa. We recently developed another modified carbapenem inactivation method (CIMTris), in which carbapenemase is extracted from bacteria with Tris-HCl buffer, to detect carbapenemase production by Acinetobacter and Pseudomonas species. This study describes an improved carbapenem inactivation method, CIMTrisII, for detecting carbapenemase production by Gram-negative pathogens, including Enterobacteriaceae, Acinetobacter and Pseudomonas species. CIMTrisII was different from CIMTris in the concentration of Meropenem disks (5-µg MEM disks vs. 10-µg MEM disks), the inoculum volume of the bacteria (a 5-µl loopful vs. a 10 µl loopful) and the incubation time (1 vs. 2 h). CIMTrisII showed an overall sensitivity of 99.3 % and an overall specificity of 95.0 % for tested isolates. In comparison, CIMTris showed a sensitivity of 96.1 % and a specificity of 96.3 %, and mCIM showed a sensitivity of 67.1 % and a specificity of 100 %. CIMTrisII is thus deemed useful for detecting carbapenemase production by Gram-negative pathogens.

Keywords: Acinetobacter species; Carbapenem inactivation method; Carbapenem resistance; Carbapenemase; Enterobacteriaceae; Pseudomonas species.

MeSH terms

  • Acinetobacter / drug effects
  • Acinetobacter / enzymology*
  • Acinetobacter / genetics
  • Anti-Bacterial Agents / pharmacology
  • Asia, Southeastern
  • Bacterial Infections / microbiology
  • Bacterial Proteins / biosynthesis*
  • Carbapenems / antagonists & inhibitors*
  • DNA, Bacterial / chemistry
  • Enterobacteriaceae / drug effects
  • Enterobacteriaceae / enzymology*
  • Enterobacteriaceae / genetics
  • Humans
  • Imipenem / pharmacology
  • Japan
  • Meropenem / pharmacology
  • Microbial Sensitivity Tests
  • Nepal
  • Pseudomonas / drug effects
  • Pseudomonas / enzymology*
  • Pseudomonas / genetics
  • Sensitivity and Specificity
  • Sequence Analysis, DNA
  • Time Factors
  • beta-Lactamases / biosynthesis*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Carbapenems
  • DNA, Bacterial
  • Imipenem
  • beta-Lactamases
  • carbapenemase
  • Meropenem